Navigation Links
Director's Forum: PEPFAR and the Global AIDS Response
Date:9/17/2007

To be webcast live at http://www.wilsoncenter.org/globalhealth

WASHINGTON, Sept. 17 /PRNewswire-USNewswire/ -- Earlier this year, President George W. Bush called for a reauthorization of the President's Emergency Plan for AIDS Relief (PEPFAR), which is set to expire at the end of fiscal year 2008. The plan calls for an increase in funding from the initial 2003 commitment of $15 billion to $30 billion over the next five years.

On September 20, 2007, the Woodrow Wilson Center's Global Health Initiative and Environmental Change and Security Program will co-host a discussion on PEPFAR principles and the global AIDS response, featuring Dr. Peter Piot, Executive Director of UNAIDS and Under Secretary-General of the United Nations, U.S. Representative Nita M. Lowey of New York's 18th District, and Kent R. Hill, Assistant Administrator for the Bureau for Global Health at the U.S. Agency for International Development (USAID).

If you are unable to attend, this event will be webcast live at http://www.wilsoncenter.org/globalhealth.

What: Director's Forum: PEPFAR and the Global AIDS Response

Who: Dr. Peter Piot, Executive Director, UNAIDS, and Under

Secretary-General, United Nations; The Honorable Nita M.

Lowey, U.S. Representative, 18th District, New York, and

Chairwoman of the State, Foreign Operations, and Related

Programs Subcommittee on Appropriations; and Kent R. Hill,

Assistant Administrator for Global Health, USAID

When: Thursday, September 20, 2007, 10:00 - 11:30 a.m.

Where: Woodrow Wilson Center, 6th Floor Flom Auditorium

The Woodrow Wilson Center is located in the Ronald Reagan

Building and International Trade Center at 1300 Pennsylvania

Avenue, N.W.

Space is limited; please RSVP to globalhealth@wilsoncenter.org with your name and affiliation. Media with questions should contact Sharon McCarter at sharon.mccarter@wilsoncenter.org or (202) 691-4016.

The Woodrow Wilson International Center for Scholars is the living, national memorial to President Wilson established by Congress in 1968 and headquartered in Washington, D.C. The Center establishes and maintains a neutral forum for free, open, and informed dialogue. It is a nonpartisan institution, supported by public and private funds and engaged in the study of national and world affairs.


'/>"/>
SOURCE Woodrow Wilson International Center for Scholars
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
2. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
3. New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
4. Global Rabies Treatment May be Possible with NanoViricides Drugs
5. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
6. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
7. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
8. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
9. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
10. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
11. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... Oct. 10, 2017   West Pharmaceutical Services, Inc. ... for injectable drug administration, today shared the results of ... for improving the intradermal administration of polio vaccines. The ... Summit in May 2017 by Dr. Ondrej Mach ... World Health Organization (WHO), and recently published in the ...
(Date:10/4/2017)... Oct. 4, 2017  According to the Centers for Disease Control and ... October . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the ... certain health insurance regulations. ... time to get a flu shot is by the end of October, ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
Breaking Medicine News(10 mins):